From Wikipedia, the free encyclopedia
MenatetrenoneFile:Menatetrenone.PNG |
Systematic (IUPAC) name |
---|
2-methyl-3-[(2Z,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl]naphthoquinone |
Identifiers |
---|
CAS number | 863-61-6 |
ATC code | none |
PubChem | 5282367 |
Chemical data |
---|
Formula | C31H40O2 |
Mol. mass | 444.648 g/mol |
Synonyms | 3-methyl-2-[(2Z,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraenyl]naphthalene-1,4-dione |
Pharmacokinetic data |
---|
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations |
---|
Pregnancy cat. | ? |
Legal status |
Routes | Oral
|
Menatetrenone (INN) is a menaquinone compound used as a hemostatic agent and as adjunctive therapy for the pain of osteoporosis. It is marketed for the latter indication in Japan by Eisai Co., under the trade name Glakay.
It is also known as Vitamin K2, but there are several menaquinone forms that are also referred to as Vitamin K2. Menatetrenone is just one of nine forms.[1]
See also
References
External links
Vitamins (A11) |
---|
|
Fat soluble | | | |
| D2 (Ergosterol, Ergocalciferol) · D3 (7-Dehydrocholesterol, Previtamin D3, Cholecalciferol, 25-hydroxycholecalciferol, Calcitriol (1,25-dihydroxycholecalciferol), Calcitroic acid)
D4 ( Dihydroergocalciferol) · D5 · D analogues ( Dihydrotachysterol, Calcipotriol, Tacalcitol, Paricalcitol) | |
| | |
| |
| |
Water soluble | | B1 (Thiamine) · B2 (Riboflavin) · B3 (Niacin, Nicotinamide) · B5 (Pantothenic acid, Dexpanthenol, Pantethine) · B6 (Pyridoxine, Pyridoxal phosphate, Pyridoxamine)
B7 ( Biotin) · B9 ( Folic acid, Dihydrofolic acid, Folinic acid) · B12 ( Cyanocobalamin, Hydroxocobalamin, Methylcobalamin, Cobamamide) · Choline | |
| |
| |
|
|